BOPA Passport and UTIC

Over the next few days we will rolling out an update to the current Passport content based on user feedback and errors highlighted. This includes updates to MCQs and a new element in the core module – UTIC.  The UTIC course (Understanding Targeted therapies and Immunotherapies for Cancer), delivered by Elaine Vickers, will be a compulsory core component for Passport users going forward, and as an optional learning component to those already registered (it will not be shown in the passport but can be completed as extra).

 

This course is available via the BOPA website and the ISOPP website. After completion of the 5 modules, you will be awarded a certificate, which can be uploaded to the BOPA Passport as evidence.  For more information on the course visit: https://www.bopa.org.uk/utic/

 

The Passport Pillar wish to thank the membership for their involvement in ensuring the Passport content is relevant and correct and welcome ongoing feedback. Please send any queries or comments to: [email protected]

 

Sarah Mitchell (BOPA Passport Lead and Clinical Pharmacist | Beatson West of Scotland Cancer Centre )

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article